The founding Board of Directors for Innovocracy consists of entrepreneurs who view the creation of Innovocracy as a start-up operation- not unlike those our system is funding. This approach means launching fast and constantly improving as we go. We believe that this helps us in understanding the motivations behind innovation and the Innovators.

• Mikael Totterman, Chairman.  Mr. Totterman is a serial entrepreneur and a founder of iCardiac Technologies.  Prior to iCardiac Technologies Mr. Totterman was the Chief Operating Officer of VirtualScopics Inc. (NASDAQ: VSCP), a leading developer of image-based biomarkers for improving pharmaceutical development. During his tenure at VirtualScopics, he led several of rounds of venture capital funding as well as striking strategic investment relationships with Pfizer, Inc. and GE Healthcare. Additionally, he was instrumental in developing VirtualScopics original business plan and overseeing the growth of the organization. Earlier in his career, Mr. Totterman also served as a principal at 3Com Ventures, a $250 million venture capital fund based in Santa Clara, CA as well as building 3Com’s Network of Global Strategic Alliances with companies including Philips, Siemens, AT&T and British Telecom. He has also held positions at Boston Consulting Group as well as Gemini Consulting. Mr. Totterman received his Bachelor’s Degree in Engineering from Stanford University where he was a David Starr Jordan Scholar and his Masters of Business Administration from the Amos Tuck School at Dartmouth College.

• Richard Glaser, Director.  Richard Glaser started his career as an investment banker in Merrill Lynch's mergers and acquisitions department. He spent most of his career as a private equity investor, investing directly in growing companies and serving as director of numerous service, manufacturing and high tech companies. He has worked closely with entrepreneurs and business owners as an investor and advisor.  Richard has been an adjunct professor at the Rochester Institute of Technology, teaching entrepreneurship to graduate students. He has also been active in the entrepreneurial and economic development community in Rochester. Richard co-founded and was president of Digital Rochester and was an original board member of the Greater Rochester Enterprise. He also served as a board member of the Venture Investors Association of New York and annual giving chair of Haverford College.  Richard uses his experience as an investment banker, investor and entrepreneur to focus on providing clients with a diverse range of specialized services.

• Ralph J. Dandrea, Director. Ralph Dandrea is President and founder of ITX Corp, a strategic business and technology solutions firm. For more than a decade, Mr. Dandrea has specialized in business and technology consulting. His extensive experience in executive information technology management for large implementations resulted in the development of several methodologies for the efficient delivery of professional services. In providing strategic IT planning for firms in such diverse industries as banking, healthcare, eCommerce, and ePublishing, and Mr. Dandrea creates linkage between organizations’ strategic goals and technology. Mr. Dandrea earned his Bachelor of Science degree in Finance from the Rochester Institute of Technology. He received his Master of Business Administration and Juris Doctor, from the State University of New York at Buffalo. He is currently certified as a Microsoft Certified Systems Engineer (M.C.S.E.).

• Alex Zapesochny, Director. Mr. Zapesochny is a serial entrepreneur, experienced technology executive and attorney who is also a founder of iCardiac Technologies. Previously, as General Counsel and Director of Business Development for Lenel Systems International, a developer and global supplier of high-end software, products and services for the security industry, Mr. Zapesochny was part of a small executive management team that guided the company to extraordinary growth. The company expanded to serving over 10,000 organizations throughout 75 countries, including security-conscious entities such as Microsoft, Cisco, all three New York City-area airports, the Department of Homeland Security and over sixty percent of all Fortune 100 companies. The company’s financial growth earned it 39th place on Inc. magazine’s ranking of the nation’s fastest-growing privately-held companies, and Lenel was acquired for $440 million by United Technologies Corporation (NYSE: UTX) in March 2005. Mr. Zapesochny remained with UTC after the acquisition and continued in his legal and business development roles within the Lenel Systems subsidiary. In private practice, Mr. Zapesochny has provided legal and business counsel to early-stage companies. Mr. Zapesochny’s other experience includes being a trial attorney during his tenure as a New York City prosecutor, a policy division staff member in the Washington headquarters of a presidential campaign, and Co-Founder and Executive Director of an award-winning non-profit that expands the national registry of potential bone marrow and blood stem cell donors. Mr. Zapesochny received his undergraduate degree from Cornell University and graduate degrees from American University and the University of Oxford.

• Alexandra Latypova, Director.  Alexandra Latypova is serial entrepreneur and a founder of iCardiac Technologies. iCardiac Technologies is based on technology developed by students and faculty at the University of Rochester.  The company has received in excess of $7 million in venture capital funding and currently serves 6 of the top 10 pharmaceutical companies in addition to a broad range of clients across North America, Europe and Asia. Prior to iCardiac Technologies, Ms. Latypova headed sales and business development at VirtualScopics, Inc., a technology spin out from the University of Rochester, which achieved peak market capitalization of over $200 million (NASDAQ: VSCP). During her tenure at VirtualScopics, she expanded the client portfolio from one lead customer, Pfizer, to 6 of the top-10 pharmaceutical companies as well as multiple smaller pharmaceutical and medical device clients. In addition, she has been responsible for developing project management organization at VirtualScopics and hiring and training several project managers and business development associates. Prior to VirtualScopics, Ms. Latypova was a Manager in healthcare practice at Analysis Group, Inc., a Boston-based economics, financial and strategy consultancy, where she advised pharmaceutical clients on a wide range of issues concerning product and market development, as well as provided economic analyses and expertise in pharmaceutical litigation cases. Ms. Latypova holds Masters of Business Administration degree from the Amos Tuck School at Dartmouth College.

• Martin Edic, Director.  Martin is co-founder and CEO of 24PageBooks Inc. and a founding partner at Wing Digital, a digital marketing agency. He has served as Director of Marketing for three software-as-a-service companies, Bluetie, Techrigy and Catertrax. Martin is the author of eight business and design books. He was a founding Board member of Digital Rochester Inc. and RochesterGrowth and is involved in economic development initiatives in the Greater Rochester NY area.

• Anik Bose, Adviser. Anik Bose is a seasoned executive with experience in both information technology and biotechnology businesses. He has headed the business development functions at communications technology companies such as 3Com as well as biotechnology focused companies such as Monsanto. In his business development roles he has managed a $250MM corporate venture fund, spearheaded dozens of venture capital investments and executed numerous spin out transactions as well as several large M&A transactions over $1.4Bn in value. His venture investments include - Mesh Networks, Parthus, Cicada Semiconductor, Microtune, ADMTek, Atrica, Intransa, Sheer Networks, Air Prime, Yipes, Silicon Wave and Healthetec. On the communications technology side, Mr. Bose architected the launch of the fastest growing Asian networking company (H3C - 3Com's joint venture with Huawei), which achieved annual revenues of over $700 million and a market valuation of $1.8Bn within 36 months of launch. For Monsanto, Mr. Bose developed and implemented global biotech growth strategies targeted towards achieving a significant return on Monsanto's $10 billion of acquisitions. Mr. Bose is currently a partner at Benhamou Global Ventures. BGV is an early stage venture fund that assists entrepreneurs in building a new generation of high technology companies. Earlier in his career, Mr. Bose served as a Partner in the High Technology Practice of Deloitte Management Consulting in San Francisco. Mr. Bose holds a MBA from Boston College and BA in Economics from the University of Delhi, India.

• David Shulman, Adviser.  David is President of Wunderman New York.  David joined Wunderman in 2010 after serving as chief digital officer for WPP’s Enfatico. Prior, David was managing director of Digitas Detroit, an office he founded and ramped up to a full-service 200-person office. During his nine-year tenure at Digitas, David held senior client leadership and new business development positions across the Digitas network in Boston, New York and London for clients such as General Motors, GlaxoSmithKline, InterContinental Hotels and American Express. David was brand strategy manager at Jaguar Cars, helping to introduce the S-Type through an award-winning campaign that included TV, print, direct response and digital. David also helped start software development firm Software MacKiev in Kiev, Ukraine. David has extensive experience in the U.S. and Europe managing cross-capability teams in a range of industries including travel, electronics, and insurance, pharmaceutical and automotive. David holds a B.A. in Psychology from the University of Massachusetts and an M.B.A. from the Amos Tuck School at Dartmouth College. He lives in New York with his wife, Valerie, and daughter Ariella. When he’s not working or traveling, you’ll find him running, rock climbing or skiing.

SASHA LATYPOVA FINE ART

About the Artist -  Alexandra (Sasha) Latypova

I was born in Ukraine and moved to the United States in the 1990's.  My primary career was not related to art, but eventually I was fortunate to gain more space and time in my life to dedicate it to art learning.  I studied with Steve Carpenter a figurative artist in Rochester NY, with Sergei Chubirko - a master academic draftsman in Florence, Italy, and took several painting workshops and classes with David Leffel and Sherrie McGraw - both preeminent contemporary artists.  I am inspired by the Russian Impressionists and Realists schools of painting as I grew up visiting museums in Kiev, Moscow and St Petersburg that exhibit timeless collections of art.  I currently live at Lake Tahoe in Nevada.   

Commissions accepted.  You can purchase available artworks on this site or please inquire by email if you are interested in larger works.  

Note: if you are interested in discussion on covid topics, please see my Substack publication "Due Diligence and Art" at [ https://sashalatypova.substack.com ]

Medical technology firm [iCardiac Technologies] Inc. has inked a multiyear, multimillion-dollar deal with Pfizer Inc., which includes an undisclosed equity investment in the local firm.

The alliance will involve the development and validation of electrocardiogram-based biomarkers, using iCardiac Technologies’ software technology platform, Comprehensive Analysis of Repolarization Signal. Financial terms of the deal were not disclosed.

The companies Monday announced the agreement at the Cardiac Safety Assessment Summit conference in Arlington, Va.

Under the agreement, iCardiac and Pfizer will collaborate on a research program that includes a series of studies. Over the term of the alliance, iCardiac will receive an equity investment and technology license payment, and research and development funding. It will retain commercial rights to the validated technology platform and new biomarkers for future application in cardiac safety clinical trials and technologies, officials said. Biomarkers are often used to measure the effects or study the progress of a disease.

A cross-licensing arrangement will allow [iCardiac Technologies] to receive rights to ECG analysis technologies developed within Pfizer. The long-term goal of the deal is to improve the precision, increase the speed and decrease costs of cardiac safety clinical trials.

"We are extremely pleased that Pfizer has partnered with iCardiac in further developing iCardiacs suite of ECG-based biomarkers and its COMPAS platform technology for advancing the field of cardiac safety testing in pharmaceutical research and development," said [Alexandra "Sasha" Latypova (born 1971)], co-founder and executive vice president of iCardiac Technologies, in a statement.

Dubbed COMPAS, the [iCardiac Technologies] technology was developed over a decade at the University of Rochester's Heart Research Follow-Up Program. Researchers use it to analyze data from ECGs and other types of heart monitors, to test the safety and efficacy of drugs. Jean-Philippe Couderc, chief technology officer at iCardiac Technologies and assistant director of UR's Heart Research Follow-Up Program, is the principal inventor. UR last year licensed the technology to iCardiac Technologies.

"Cardiac safety is one of the most challenging hurdles in developing new medicines," said Kate Robbins, Pfizer spokeswoman. "We support the development of new tools that may enhance our ability to predict the safety of potential new medicines in early stages of research and development."

The company plans to use proceeds from the Pfizer investment to accelerate its research and validation efforts and hire staffers, Alex Zapesochny, president and chief operating officer at iCardiac Technologies, told the Rochester Business Journal. Located on Allens Creek Road in Brighton, the firm employs 17 full-time and contract staffers. Zapesochny did not disclose the number of positions, except to say “several more jobs,” will be added this year.

The firm this year plans to execute on its research goals related to the alliance with Pfizer and pursue other applications for its biomarkers.

"We're also going to see if we can get other companies besides Pfizer to also join with us as part of a broader cardiac safety alliance to further accelerate finding the solution to this problem," Zapesochny said. "And what that means is essentially development and validating the next generation of tools that will determine with more definitiveness whether or not drugs are safe for the heart or not."

The local firm is in the process of approaching the top 10 pharmaceutical companies to gauge their interest.

"We have very strong preliminary interest from five large pharmaceutical companies who want to get involved in this alliance because they all recognize the value of the next generation of tools and limitations of the current set of tools," [Alexandra "Sasha" Latypova (born 1971)] said in an interview.

The company hopes to structure a broader industry alliance within the next 12 months, she said.

Late last night I clicked on a YouTube video showing a very small girl, barely in her teens, and I was shocked.  In this video, she was going on a rant about how YouTube had disabled comments to all of her videos in order to protect her from possible pedophiles, which was punishing her, not the pedophiles.  She was using profanity, making sexual references, saying things that would be offensive to many people, and acting quite fierce, even though she was about 4′-11″, 90 lbs, and twelve years old.

I had never seen this girl before, and I had never heard anything about her.  Her YouTube channel name was “Soph”, and her name was Sophia.  I quickly watched three or four more of her other videos, which were even more elaborate and more impressive social commentaries than the first video of hers that I watched.

I was shocked and amazed, I had never seen a person or YouTuber like Sophia before.  I am 50 years old, for 40 years I have seen stand-up comedians who tried to become famous for their edgy, off-color, offensive, mean, profane, crude, vulgar, shocking monologues.  I have watched entertainers, journalists, television hosts, and politicians try to be witty, insightful, funny, and attention getting when it is their chance to speak.  I would say that Sophia could out do all of them.

Sophia was born in September of 2004.  She is 14 years old now, and a freshman in high school in Marin County, California.  In 2015 when Sophia was 11 years old, her parents helped her create a YouTube channel called “LtCorbis”.  From what I read on the internet, after uploading videos to her YouTube channel “LtCorbis” for roughly a year, a more popular and established YouTube channel featured one of her videos, which led to her channel quickly growing to 400,000 subscribers.

With 400K subscribers to her YouTube channel, and perhaps 500,000 to 1,000,000 views to some of her videos back in 2016 and 2017, this could have earned Sophia $200,000 to $400,000 from YouTube, when she was 12 or 13 years old.

Then, YouTube began to act very strangely toward its YouTube channel creators.  Some of the most provocative, shocking, and outrageous YouTube channel creators like Sophia had their channels grow to more than 500K subscribers, with some of their YouTube videos receiving millions of views.  According to the formula used by YouTube to determine how they paid the YouTube channel creators based on their number of subscribers and video views, each of these most popular channel creators would have been owed several hundred thousand dollars.  But YouTube began trying to not pay channel creators by using a policy called “demonitization”.

The owner of YouTube, which is Google, began to claim that the provocative, shocking, and outrageous videos were causing complaints from advertisers, parents, religious groups, organizations, schools, law enforcement, and so on. YouTube began to inform channel creators that their videos were being “demonitized” because they showed acts of violence, minors being exploited, racism, nudity, etcetera.  Keep in mind that these videos were still available to watch on YouTube and they received millions of views, but YouTube had found a way to get out of paying the channel creators for these videos.

Currently, Sophia’s YouTube Channel “Soph” has 900,000 subscribers.  With the amount of views her videos receive, the amount of people on YouTube who watch her videos, the amount of advertising that her viewers watch, Sophia should have been paid more than $1 million over the past several years from YouTube, but her videos have been demonitized.

In May of 2019, it was reported that the Police had to conduct an investigation of 14 year old Sophia after she posted the following comment about Susan Wojcicki, the CEO of YouTube:

“Susan, I’ve known your address since last summer, I’ve got a Luger and a mitochondrial disease. I don’t care if I live. Why should I care if you live or your children? I just called an Uber.  You’ve got about seven minutes to draft up a will. … I’m coming for you, and it ain’t gonna be pretty.”

In total, I have watched about ten of Sophia’s videos.  Below I am including one of the “worst” of Sophia’s videos.  I am warning viewers about the bad language and sexual references in this video, though she makes many good points and observations:

Like me, many men would like to leave antagonizing, irritating, and mean comments to Sophia’s videos in order to make her mad, but in order to not allow things to get even more out of control, YouTube won’t allow comments to any of her videos.

I continued to watch more of Sophia’s videos to hear what she had to say, and to learn more about her.  I learned that she was a student at Redwood High School in Marin County, California, probably the most expensive and affluent area in the United States.  She recorded one of her videos on the porch of her family’s home, which showed miles of undeveloped forests behind her porch, which in California would certainly be a multi-million dollar home.

In another one of Sophia’s videos, she was doing her homework on a thick pad of green engineering form paper, which is expensive, and usually the only people who use this special grid paper are professional engineers or engineering students in their last couple of years in college.  I thought that her father must be a very successful engineer to live in Marin County, and leave engineering form paper pads laying around for his daughter to use.

Here is a video where I began to get a little more insight into how intelligent Sophia is, what she has been through, and what her parents are like, where she does admit that her father had “some kind of engineering degree”.  This video below would lead me to look for and find out who her father is:

Sophia’s father is Mikael Totterman, a very successful bio-medical engineer with a Bachelor of Science in engineering from Stanford University in California, and a Master of Business Administration from Dartmouth College in New Hampshire.  He has founded and been the CEO of several large successful medical technology companies:  https://www.linkedin.com/in/totterman

Sophia’s mother is Alexandra “Sasha” Latypova.  Sasha was born in Ukraine, and she met Mikael Totterman while enrolled at the MBA program at Dartmouth College in the late 1990s.  They became married in 2000.  If you look on the internet, Sasha is listed as co-founder and director of the medical tech company Clerio Vision, and she also appears to be a painter.

Update 8/5/2019:

Sophia’s YouTube Channel has been deleted by YouTube.  Here is the link to her videos on BitChute  https://www.bitchute.com/channel/soph/

Here are a few responses from Sophia’s followers:

Cocoa The Clown 3 days ago,

“She really puts many adults to shame, such a young girl knows more about how the world works than most adults.”

Invid of INP 3 days ago,

“When a little girl threatens their entire world…”

Impervious 3 days ago,

“A 14 year old vs $140 billion corporation… oh, my.”

Miguel Jimenez 3 days ago,

“Feminism: WE WANT WOMEN TO SPEAK THEIR MIND Also feminism: Ban this girl for speaking her mind, she’s harming muh feelings.”

Ben M 3 days ago,

“The further a society drifts from the truth, the more it will hate those that speak it.” ― George Orwell